These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 20938132)
1. Beta-2-microglobulin as a uremic toxin: the Japanese experience. Fujimori A Contrib Nephrol; 2011; 168():129-133. PubMed ID: 20938132 [TBL] [Abstract][Full Text] [Related]
2. New uremic toxins - which solutes should be removed? Glorieux G; Vanholder R Contrib Nephrol; 2011; 168():117-128. PubMed ID: 20938131 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Circulating Levels of Uremic Toxins in Hemodialysis Patients Treated with Medium Cut-Off Membranes and High-Flux Membranes: Theranova in Sisli Hamidiye Etfal (THE SHE) Randomized Control Study. Sevinc M; Hasbal NB; Yilmaz V; Basturk T; Ahbap E; Sakaci T; Ozcafer PN; Unsal A Blood Purif; 2020; 49(6):733-742. PubMed ID: 32634815 [TBL] [Abstract][Full Text] [Related]
4. Effect of large-size dialysis membrane and hemofiltration/hemodiafiltration methods on long-term dialysis patients. Tsuchida K; Minakuchi J Contrib Nephrol; 2011; 168():179-187. PubMed ID: 20938139 [TBL] [Abstract][Full Text] [Related]
6. Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and post-dilution hemodiafiltration. Krieter DH; Falkenhain S; Chalabi L; Collins G; Lemke HD; Canaud B Kidney Int; 2005 Jan; 67(1):349-56. PubMed ID: 15610261 [TBL] [Abstract][Full Text] [Related]
7. Clinical comparison of super high-flux HD and on-line HDF. Fujimori A Blood Purif; 2013; 35 Suppl 1():81-4. PubMed ID: 23466386 [TBL] [Abstract][Full Text] [Related]
8. Optical Method and Biochemical Source for the Assessment of the Middle-Molecule Uremic Toxin β2-Microglobulin in Spent Dialysate. Paats J; Adoberg A; Arund J; Fridolin I; Lauri K; Leis L; Luman M; Tanner R Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807387 [TBL] [Abstract][Full Text] [Related]
9. Will nephrologists use a wearable artificial kidney? Friedman EA Clin J Am Soc Nephrol; 2009 Sep; 4(9):1401-2. PubMed ID: 19661217 [No Abstract] [Full Text] [Related]
10. Markers and possible uremic toxins: Japanese experiences. Kinugasa E Contrib Nephrol; 2011; 168():134-138. PubMed ID: 20938133 [TBL] [Abstract][Full Text] [Related]
11. [Chronic renal failure: present and future. Pathophysiology and metabolic abnormalities--uremic toxin, middle and large molecular substances]. Gejyo F Nihon Naika Gakkai Zasshi; 1986 Nov; 75(11):1550-4. PubMed ID: 3546560 [No Abstract] [Full Text] [Related]
12. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β Yamamoto S Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756 [TBL] [Abstract][Full Text] [Related]
13. HDF promise for the future. Lornoy W; De Meester J Nephrol Dial Transplant; 2008 Aug; 23(8):2705-6; author reply 2706-7. PubMed ID: 18495747 [No Abstract] [Full Text] [Related]
14. [Middle-molecule uremic toxins: A renewed interest]. Nlandu Y; Padden M; Seidowsky A; Hamaz S; Vilaine É; Cheddani L; Essig M; Massy ZA Nephrol Ther; 2019 Apr; 15(2):82-90. PubMed ID: 30954165 [TBL] [Abstract][Full Text] [Related]
15. Comparison of toxin removal outcomes in online hemodiafiltration and intra-dialytic exercise in high-flux hemodialysis: a prospective randomized open-label clinical study protocol. Maheshwari V; Samavedham L; Rangaiah GP; Loy Y; Ling LH; Sethi S; Leong TL BMC Nephrol; 2012 Nov; 13():156. PubMed ID: 23176731 [TBL] [Abstract][Full Text] [Related]
16. High-Flux Dialysis: Clinical, Biochemical, and Proteomic Comparison with Low-Flux Dialysis and On-Line Hemodiafiltration. Donadio C; Kanaki A; Sami N; Tognotti D Blood Purif; 2017; 44(2):129-139. PubMed ID: 28571019 [TBL] [Abstract][Full Text] [Related]